title: Capecitabine cardiotoxicity: How to limit life-threatening events.
authors.affiliation: Cardiology, Oncology and Radiation Oncology Units, CRO, National Cancer Institute, Aviano, PN, Italy. Electronic address: clestuzzi@cro.it.
authors.forename: Chiara
authors.initials: C
authors.lastname: Lestuzzi
authors.affiliation: Cardiology, Oncology and Radiation Oncology Units, CRO, National Cancer Institute, Aviano, PN, Italy.
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Berretta
authors.affiliation: Cardiology, Oncology and Radiation Oncology Units, CRO, National Cancer Institute, Aviano, PN, Italy.
authors.forename: Antonino
authors.initials: A
authors.lastname: De Paoli
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects; D000069287:Capecitabine / Q000008:administration & dosage / Q000009:adverse effects*; D066126:Cardiotoxicity / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D016903:Drug Monitoring / Q000379:methods; D064420:Drug-Related Side Effects and Adverse Reactions / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control; D006801:Humans
chemical_list: D000964:Antimetabolites, Antineoplastic; D000069287:Capecitabine